These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9858970)

  • 21. [Minor differences in outcome comparing early vs. later initiation of medicamentous blood glucose control in type 2 diabetic patients].
    Ritzman P
    Praxis (Bern 1994); 1999 Aug; 88(31-32):1289-90. PubMed ID: 10479970
    [No Abstract]   [Full Text] [Related]  

  • 22. Enalapril, a nonsulfhydryl angiotensin-converting enzyme inhibitor.
    Vlasses PH; Larijani GE; Conner DP; Ferguson RK
    Clin Pharm; 1985; 4(1):27-40. PubMed ID: 2982541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
    Ross SA; Zinman B; Campos RV; Strack T;
    Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Measures to meet the side effects of sulfonylurea (SU) in the treatment of type 2 diabetes].
    Furukawa H; Ishida H
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():357-61. PubMed ID: 12387018
    [No Abstract]   [Full Text] [Related]  

  • 25. HYPOGLYCEMIA INDUCED BY ANTIDIABETIC SULFONYLUREAS.
    Confederat L; Constantin S; Lupaşcu F; Pânzariu A; Hăncianu M; Profire L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):579-84. PubMed ID: 26204670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Severe hypoglycemia due to insulin. Risks and adverse effects of antidiabetic drugs].
    Auzepy P; Caquet R
    Sem Hop; 1983 Mar; 59(10):697-705. PubMed ID: 6304892
    [No Abstract]   [Full Text] [Related]  

  • 27. Severe hypoglycemia is associated with antidiabetic oral treatment compared with insulin analogs in nursing home patients with type 2 diabetes and dementia: results from the DIMORA study.
    Abbatecola AM; Bo M; Barbagallo M; Incalzi RA; Pilotto A; Bellelli G; Maggi S; Paolisso G;
    J Am Med Dir Assoc; 2015 Apr; 16(4):349.e7-12. PubMed ID: 25669671
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between interstitial and blood glucose during hypoglycemia in subjects with type 2 diabetes.
    Choudhary P; Lonnen K; Emery CJ; Freeman JV; McLeod KM; Heller SR
    Diabetes Technol Ther; 2011 Nov; 13(11):1121-7. PubMed ID: 21790477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of angiotensin-converting enzyme inhibition on prolactin responses in normal and hyperprolactinemic subjects.
    Anderson PW; Malarkey WB; Salk J; Kletsky OA; Hsueh WA
    J Clin Endocrinol Metab; 1989 Sep; 69(3):518-22. PubMed ID: 2503532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of effects of combined ACE inhibitor and low-dose thiazide diuretic with ACE inhibitor alone on insulin action in patients with hypertension and Type 2 diabetes: a double-blind crossover study.
    McLaughlin DM; Atkinson AB; Ennis CN; Browne J; Hunter SJ; Sheridan B; Bell PM
    Diabet Med; 2008 May; 25(5):631-4. PubMed ID: 18445178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reconsideration of severe hypoglycemic events in the treat-to-target trial.
    Dailey G; Strange P; Riddle M
    Diabetes Technol Ther; 2009 Aug; 11(8):477-9. PubMed ID: 19698059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hypoglycemia caused by interference between an angiotensin-converting enzyme inhibitor and a hypoglycemic sulfonamide].
    Veyre B; Ginon I; Vial T; Dragol F; Daumont M
    Presse Med; 1993 Apr; 22(15):738. PubMed ID: 8511130
    [No Abstract]   [Full Text] [Related]  

  • 34. Antihypertensives and the risk of serious hypoglycemia in older persons using insulin or sulfonylureas.
    Shorr RI; Ray WA; Daugherty JR; Griffin MR
    JAMA; 1997 Jul; 278(1):40-3. PubMed ID: 9207336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measures to meet the side effects of the orally administered antihyperglycemic drugs].
    Ishii J; Inoue I
    Nihon Rinsho; 1997 Nov; 55 Suppl():104-13. PubMed ID: 9434452
    [No Abstract]   [Full Text] [Related]  

  • 36. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
    Cody RJ; Laragh JH; Atlas SA; Case DB
    J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Combined insulin-sulfonylurea in type II diabetes mellitus--an update].
    Ravina A; Minuchin O
    Harefuah; 1987 Nov; 113(10):285-7. PubMed ID: 3326798
    [No Abstract]   [Full Text] [Related]  

  • 38. Emergency management of oral hypoglycemic drug toxicity.
    Rowden AK; Fasano CJ
    Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The combination of insulin and oral hypoglycaemic drugs: a continuous challenge.
    Quatraro A; Giugliano D
    Diabete Metab; 1993; 19(2):219-24. PubMed ID: 8339852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.